Sana Biotechnology, Inc. (SANA)
NASDAQ: SANA · Real-Time Price · USD
1.500
-0.180 (-10.71%)
At close: Apr 1, 2025, 4:00 PM
1.501
+0.001 (0.05%)
After-hours: Apr 1, 2025, 7:46 PM EDT

Sana Biotechnology Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2018
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2018
Net Income
-266.76-283.26-269.48-355.93-285.31
Upgrade
Depreciation & Amortization
15.517.5415.6311.075.92
Upgrade
Asset Writedown & Restructuring Costs
1.897.01---
Upgrade
Stock-Based Compensation
37.6835.5338.3422.365.83
Upgrade
Other Operating Activities
-10.28-49.03-82.0861.64129.42
Upgrade
Change in Accounts Payable
1.381.031.06-0.271.98
Upgrade
Change in Other Net Operating Assets
-2.5617.586.4810.074.17
Upgrade
Operating Cash Flow
-223.15-253.58-290.05-251.05-137.98
Upgrade
Capital Expenditures
-33.43-20.03-20.88-29.86-23.87
Upgrade
Investment in Securities
50.88192.04231.44-211.36-228.69
Upgrade
Other Investing Activities
----4.57-
Upgrade
Investing Cash Flow
17.45172.01210.56-245.8-252.56
Upgrade
Long-Term Debt Issued
7.74----
Upgrade
Net Debt Issued (Repaid)
7.74----
Upgrade
Issuance of Common Stock
192.0131.654.91631.750.15
Upgrade
Financing Cash Flow
199.7531.654.91631.75435.69
Upgrade
Net Cash Flow
-5.95-49.92-74.58134.945.14
Upgrade
Free Cash Flow
-256.58-273.61-310.93-280.92-161.85
Upgrade
Free Cash Flow Per Share
-1.11-1.41-1.65-1.69-12.44
Upgrade
Levered Free Cash Flow
-168.6-206.93-140.89-138.16-166.01
Upgrade
Unlevered Free Cash Flow
-168.6-206.93-140.89-138.16-166.01
Upgrade
Change in Net Working Capital
18.6835.674.33-61.44-8.84
Upgrade
Updated Mar 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q